BACKGROUND AND PURPOSE: The aim of the study was to analyse the lifetime of Soletra implantable pulse generators (IPG) in deep brain stimulation (DBS) of the globus pallidus internus (GPi) for dystonia, depending on stimulation parameters and the total electrical energy delivered (TEED) by the IPG. METHODS: In a prospective series of 20 patients with GPi DBS for dystonia, we recorded IPG longevity and stimulation parameters over time. An evaluation of the TEED was performed using the previously suggested equation [(voltage(2) × pulse width × frequency)/impedance] × 1 s. RESULTS: During median follow-up of 57 months (range 23-79 months), 64 IPGs were replaced because of battery depletion or end of life signal. We found a mean IPG longevity of 25.1 ± 10.1 (range 16-60) months, which was inversely correlated with the TEED (r = -0.72; P < 0.001). IPG longevity was not different between bipolar and monopolar stimulation (24.9 ± 10.8 vs. 25.4 ± 9.0 months, P = 0.76). Incongruously, the mean TEED applied throughout the lifetime cycle was significantly higher in patients with bipolar compared with monopolar stimulation (584 ± 213 vs. 387 ± 121 Joule; P < 0.01). CONCLUSIONS: Battery lifetime in GPi DBS for dystonia is substantially shorter compared with that reported in DBS for Parkinson's disease, caused by a considerably higher voltage and greater pulse width and therefore a higher TEED applied during the battery lifetime cycle. The commonly used equation to calculate TEED, however, seems to be correct only for monopolar, but not bipolar stimulation.
BACKGROUND AND PURPOSE: The aim of the study was to analyse the lifetime of Soletra implantable pulse generators (IPG) in deep brain stimulation (DBS) of the globus pallidus internus (GPi) for dystonia, depending on stimulation parameters and the total electrical energy delivered (TEED) by the IPG. METHODS: In a prospective series of 20 patients with GPi DBS for dystonia, we recorded IPG longevity and stimulation parameters over time. An evaluation of the TEED was performed using the previously suggested equation [(voltage(2) × pulse width × frequency)/impedance] × 1 s. RESULTS: During median follow-up of 57 months (range 23-79 months), 64 IPGs were replaced because of battery depletion or end of life signal. We found a mean IPG longevity of 25.1 ± 10.1 (range 16-60) months, which was inversely correlated with the TEED (r = -0.72; P < 0.001). IPG longevity was not different between bipolar and monopolar stimulation (24.9 ± 10.8 vs. 25.4 ± 9.0 months, P = 0.76). Incongruously, the mean TEED applied throughout the lifetime cycle was significantly higher in patients with bipolar compared with monopolar stimulation (584 ± 213 vs. 387 ± 121 Joule; P < 0.01). CONCLUSIONS: Battery lifetime in GPi DBS for dystonia is substantially shorter compared with that reported in DBS for Parkinson's disease, caused by a considerably higher voltage and greater pulse width and therefore a higher TEED applied during the battery lifetime cycle. The commonly used equation to calculate TEED, however, seems to be correct only for monopolar, but not bipolar stimulation.
Authors: Daniel E Lumsden; Margaret Kaminska; Kylie Tustin; Hortensia Gimeno; Lesley Baker; Keyoumars Ashkan; Richard Selway; Jean-Pierre Lin Journal: Childs Nerv Syst Date: 2012-03-18 Impact factor: 1.475
Authors: Kyle T Mitchell; Monica Volz; Aaron Lee; Marta San Luciano; Sarah Wang; Philip A Starr; Paul Larson; Nicholas B Galifianakis; Jill L Ostrem Journal: Stereotact Funct Neurosurg Date: 2019-07-09 Impact factor: 1.875
Authors: Pawan V Rawal; Leonardo Almeida; Luke B Smelser; He Huang; Barton L Guthrie; Harrison C Walker Journal: Brain Stimul Date: 2014-01-18 Impact factor: 8.955
Authors: Leonardo Almeida; Pawan V Rawal; Benjamin Ditty; Bryan L Smelser; He Huang; Michael S Okun; Barton L Guthrie; Harrison C Walker Journal: Mov Disord Clin Pract Date: 2016-01-09
Authors: Simon Little; Alex Pogosyan; Spencer Neal; Baltazar Zavala; Ludvic Zrinzo; Marwan Hariz; Thomas Foltynie; Patricia Limousin; Keyoumars Ashkan; James FitzGerald; Alexander L Green; Tipu Z Aziz; Peter Brown Journal: Ann Neurol Date: 2013-07-12 Impact factor: 10.422
Authors: Svilen D Angelov; Sven Koenen; Jurij Jakobi; Hans E Heissler; Mesbah Alam; Kerstin Schwabe; Stephan Barcikowski; Joachim K Krauss Journal: J Nanobiotechnology Date: 2016-01-12 Impact factor: 10.435
Authors: Kaihan Fakhar; Erin Hastings; Christopher R Butson; Kelly D Foote; Pam Zeilman; Michael S Okun Journal: PLoS One Date: 2013-03-11 Impact factor: 3.240
Authors: Umer Akbar; Robert S Raike; Nawaz Hack; Christopher W Hess; Jared Skinner; Daniel Martinez-Ramirez; Sol DeJesus; Michael S Okun Journal: Neuromodulation Date: 2016-03-22